Page last updated: 2024-08-17

methylene blue and Encephalopathy, Traumatic

methylene blue has been researched along with Encephalopathy, Traumatic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Genrikhs, EE; Isaev, NK; Kapkaeva, MR; Kondratenko, RV; Mukhaleva, EV; Skrebitsky, VG; Stelmashook, EV1
Alexandrova, OP; Fedorov, AV; Genrikhs, EE; Isaev, NK; Novikova, SV; Stelmashook, EV; Voronkov, DN1
Lin, AL; Sullivan, PG; Talley Watts, L; Vekaria, HJ1
Baek, S; Baik, JH; Choi, E; Jeong, K; Kim, B; Kim, D; Kim, S; Kim, YK; Lee, BH; Lee, JJ; Lee, KP; Lim, S; Park, J; Shin, S1

Reviews

1 review(s) available for methylene blue and Encephalopathy, Traumatic

ArticleYear
Targeting mitochondrial dysfunction in CNS injury using Methylene Blue; still a magic bullet?
    Neurochemistry international, 2017, Volume: 109

    Topics: Animals; Brain; Brain Injuries, Traumatic; Central Nervous System Diseases; Drug Delivery Systems; Energy Metabolism; Humans; Methylene Blue; Mitochondria

2017

Other Studies

3 other study(ies) available for methylene blue and Encephalopathy, Traumatic

ArticleYear
Neuroprotective Effects of Methylene Blue In Vivo and In Vitro.
    Bulletin of experimental biology and medicine, 2019, Volume: 167, Issue:4

    Topics: Animals; Brain Injuries, Traumatic; Cells, Cultured; Male; Methylene Blue; Neurons; Neuroprotective Agents; Paraquat; Rats, Wistar

2019
The single intravenous administration of methylene blue after traumatic brain injury diminishes neurological deficit, blood-brain barrier disruption and decrease in the expression of S100 protein in rats.
    Brain research, 2020, 08-01, Volume: 1740

    Topics: Administration, Intravenous; Animals; Blood-Brain Barrier; Brain Injuries, Traumatic; Cells, Cultured; Enzyme Inhibitors; Gene Expression; Hand Strength; Male; Methylene Blue; Nervous System Diseases; Neuroprotective Agents; Rats; Rats, Wistar; S100 Proteins

2020
Nootropic nanocomplex with enhanced blood-brain barrier permeability for treatment of traumatic brain injury-associated neurodegeneration.
    Journal of controlled release : official journal of the Controlled Release Society, 2018, 08-28, Volume: 284

    Topics: Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Brain Injuries, Traumatic; Cell Line; Drug Carriers; Humans; Male; Methylene Blue; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Nanostructures; Neurodegenerative Diseases; Neuroprotective Agents; Nootropic Agents; Permeability; Poloxamer

2018